In vitro metabolism of mifepristone (RU-486) in rat, monkey and human hepatic S9 fractions: Identification of three new mifepristone metabolites

Xenobiotica

Volumn 29, Issue 11, 1999, Pages 1089-1100

  Wu, W N ^a   Mckown, L A ^a   Moyer, M D ^a   Johannsen, T B ^a   Takacs, A R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; DRUG METABOLITE; FORMYLMIFEPRISTONE; HYDROXYMETHYLMIFEPRISTONE; MIFEPRISTONE; N DESMETHYLMIFEPRISTONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER; MALE; MASS SPECTROMETRY; MONKEY; NONHUMAN; OXIDATION; RAT;

ANIMALIA;

EID: 0032695229     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599237976     Document Type: Article

References (13)

1. BROGDEN, R. N., GOA, K. L. and FAULDS, D., 1993, Mifepristone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs, 45, 384-409.
2. CHASSEROT-GOLAZ, S., BECK, G. and VENETIANER, A., 1993, Biotransformation of 17β-hydroxy-11β-(4-dimethylaminophenyl)17α-1-propynyl-estra-4,9- dien-3-one (RU486) in rat hepatoma variants. Biochemical Pharmacology, 46, 2100-2103.
3. DERAEDT, R., BONNAR, C., BUSIGNY, M., CHATELET, P., COUSTY, C., MOUREA, M., PHILIBERT, D., POTTIER, J. and SALMON, J., 1985, Pharmacokinetics of RU 486. In E. E. Baulieu and S. Segal (eds), The Antiprogestin Steroid RU 486 and Human fertility Control (New York: Plenum), pp. 103-122.
4. FOLDESI, I., FALKAY, G. and KOVACS, L., 1996, Determination of RU486 (mifepristone) in blood by radioreceptorassay: a pharmacokinetic study. Contraception, 54, 27-32.
5. HE, C., ZHANG, G., BAI, X., JIANG, N., ZHOU, W., GUI, Y., FAN, Q. and CHEN, J., 1994, Pharmacokinetics of mifepristone (RU486) and its metabolites in pregnant women. Shengzhi Yu Biyun, 14, 280-286.
6. HEIKINHEIMO, O., KONTULA, K., CROXATTO, H., SPITZ, I. and LUUKKAINEN, T., 1987a, Plasma concentrations and receptor binding of RU 486 and its metabolites in humans. Journal of Steroid Biochemistry, 26, 279-284.
7. HEIKINHEIMO, O., LAHTEENMAKI, P., KOIVUNEN, E., SHOUPE, D. and CROXATTO, H., 1987b, Metabolism and serum binding of RU 486 in women after various single doses. Human Reproduction, 2, 379-385.
8. JANG, G. R., WRIGHTON, S. A. and BENET, L. Z., 1996, Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Biochemical Pharmacology, 52, 753-761.
9. LAHTEENMAKI, P., HEIKINHEIMO, O., CROXATTO, H., SPITZ, I., SHOUPE, D., BIRGERSON, L. and LUUKKAINEN, 1987, Phamcokinetics and metabolism of RU 486. Journal of Steroid Biochemistry, 27, 859-863.
10. NAGOSHI, K., HAYASHI, N. and SEKIBA, K., 1991, Automated direct assay system for RU38486, an antiprogesterone-anti-glucocorticoid agent, and its metabolites using high performance liquid chromatography. Acta Medica Okayama, 45, 81-87.
11. SHI, Y., YE, Z., HE, C., ZHANG, G., XU, J., VAN, L. and FORTHERBY, K., 1993, pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception, 48, 133-149.
12. ULMANN, A., TEUTSCH, G. and PHILIBERT, D., 1990, RU 486. Scientific American, 262, 42-48.
13. WU, W. N., MCKOWN, L. A. and TAKACS, A. R., 1997, Identification of three new mifepristone (RU-486) metabolites in rat, monkey, and human hepatic S9 fractions. In ISSX Proceedings, 45 (abstract, The 8th North American ISSX Meeting).